Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Randomized, Double-blind, Double-dummy, Active-drug-controlled, Parallel-group, Multicentre Acceptability and Safety Study of the Transfer From Subutex/Suboxone to RBP-6300 in Opioid-dependent Subjects

NCT01582347 is registered in ClinicalTrials.gov with Indivior Inc. as lead sponsor.

NCT NCT01582347
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01582347 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Randomized, Double-blind, Double-dummy, Active-drug-controlled, Parallel-group, Multicentre Acceptability and Safety Study of the Transfer From Subutex/Suboxone to RBP-6300 in Opioid-dependent Subjects
Lead sponsor
Indivior Inc.
Phase
Phase 2
Overall status
Completed
Start date
March 31, 2012
Completion date
November 30, 2012
Enrollment
143 (actual)
Sites
15

Conditions

As the registry lists them; a condition with its own page is linked.

opioid related disorder